LOOMIS SAYLES & CO L P - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q4 2018$35,508,000
-23.0%
656,832
-0.0%
0.08%
-6.7%
Q3 2018$46,086,000
+22.5%
656,983
+14.7%
0.09%
+18.4%
Q2 2018$37,608,000
+137.9%
572,994
+139.2%
0.08%
+123.5%
Q1 2018$15,807,000
+25.4%
239,496
+34.1%
0.03%
+25.9%
Q3 2017$12,606,000
-65.1%
178,649
-74.9%
0.03%
-68.2%
Q2 2017$36,154,000
+28.6%
710,705
+1.6%
0.08%
+21.4%
Q1 2017$28,116,000
-44.9%
699,403
-7.7%
0.07%
-44.0%
Q4 2016$51,061,000758,1540.12%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2018
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 83,741,000$95,429,0006.49%
STEELHEAD PARTNERS LLC 52,496,000$59,911,0005.47%
SILVERBACK ASSET MANAGEMENT LLC 23,000,000$26,278,0004.02%
Castle Creek Arbitrage, LLC 10,734,000$12,253,0003.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,132,000$45,920,0002.81%
Sonora Investment Management, LLC 16,707,000$19,084,0001.99%
TFG Asset Management GP Ltd 8,500,000$9,718,0001.73%
Verition Fund Management LLC 27,901,000$31,890,0000.88%
SSI INVESTMENT MANAGEMENT LLC 7,872,000$8,977,0000.65%
SHENKMAN CAPITAL MANAGEMENT INC 4,780,000$5,514,0000.63%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders